Stay updated on Avapritinib vs Regorafenib in GIST Clinical Trial
Sign up to get notified when there's something new on the Avapritinib vs Regorafenib in GIST Clinical Trial page.

Latest updates to the Avapritinib vs Regorafenib in GIST Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedNo significant changes observed between the old and new VOYAGER study pages for NCT03465722.SummaryDifference0.2%

- Check34 days agoChange DetectedCore content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.SummaryDifference2%

- Check41 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%

- Check56 days agoChange DetectedThe revision label updated from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed. This is a minor maintenance update with no changes to core content.SummaryDifference0.1%

- Check63 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.1%

- Check70 days agoChange DetectedThe web page has undergone significant updates, including the addition of specific facility names and locations, as well as detailed references to gastrointestinal stromal tumors and related treatments. The revision number has also been updated to v3.0.0.SummaryDifference11%

Stay in the know with updates to Avapritinib vs Regorafenib in GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avapritinib vs Regorafenib in GIST Clinical Trial page.